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Chediak-Higashi Syndrome (CHS) is a rare, autosomal recessive genetic disorder 
caused by mutations in the lysosomal trafficking regulator gene (CHS1) that affects 
vesicle morphology. The CHS1 gene encodes a protein, Lyst, which belongs to a family 
of proteins containing a conserved BEACH (BEige And Chediak-Higashi) domain and 
WD40-repeat domain. The beigej mouse has been the best-studied animal model for 
CHS. Factor associated with neutral sphingomyelinase activation or FAN is the smallest 
member of the BEACH family. FAN interacts with the Tumor Necrosis Factor Receptor 
(TNFR1) to activate Neutral SphingoMyelinase2 (NSMase2). The absence of Lyst or 
FAN gives rise to enlarged lysosomes. Loss of both proteins results in an additive effect, 
as demonstrated by increased lysosome size in FAN-/- /beigej mouse. An additive 
phenotype suggests that there are at least two pathways to regulate lysosome size. 
Overexpression of Lyst or FAN results in smaller than normal lysosomes. 
Overexpression of FAN in the absence of Lyst does not give rise to small lysosomes. 
NSMases are present on lysosomes and inhibition of NSMases, using GW4869 or 3-O-
Methylsphingomyelin, results in enlarged lysosomes. Further, the decrease in lysosome 
size seen in FAN-overexpressing cells is blocked by GW4869. These results suggest that 
FAN activation of NSMase at the lysosome is a crucial step in regulating lysosome size.
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Christian De Duve was the first to describe lysosomes as membrane bound 
organelles (Appelmans, Wattiaux and De Duve; Duve). Structurally they appear as dense 
bodies localized in a perinuclear pattern in the cytosol. Lysosomes are conserved 
throughout eukaryotes. Lysosome size can vary from 100 nm up to several microns, 
although the steady state size of lysosomes in higher eukaryotes is normally about 200-
400 nm. Depending on the cell type, lysosome shape varies from spherical to tubular 
(Lüllmann-Rauch). Lysosomes have an acidic lumen that is enclosed by a single 
phospholipid-bilayer. The lysosomal membrane is highly glycosylated, which protects 
lysosomal membrane proteins and lipids from the acidic proteases and lipases-rich 
environment. There are many lysosomal membrane proteins and integral membrane 
proteins such as Lysosome-Associated Membrane Protein (LAMP)-1 and LAMP-2, 
Lysosome Integral Membrane Protein (LIMP)-2 and CD63, which are among the most 
abundant (Saftig, Schröder and Blanz). These proteins provide integrity to the lysosomal 
membrane as well as act with other lysosomal membrane proteins in signaling. 
Soluble NSF (N-ethylmaleimide sensitive fusion proteins) Attachment protein 
Receptors (SNAREs) mediates the fusion of the lysosomes with other cellular structures 
such as other lysosomes, late endosomes, autophagosomes and the plasma membrane. 
This fusion allows for the redistribution of substrates among the lysosomes for efficient 
degradation and also functions to regulate the size of the lysosomes. Lysosomes also 
contain transporters on their surface that mediate transport of metabolites, ions and 
soluble substrates into and out of lysosomes (Saftig and Klumperman). Lysosomes have a 
vacuolar ATPase proton pump that maintains the acidic luminal pH of 4.6-5.0 (Mellman, 
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Fuchs and Helenius) for proper functioning of acid hydrolases stored in the lysosome 




Functions of Lysosomes 
Lysosome functions can be divided into three main types: degradation, secretion 
and signaling. The endocytic pathway transports extracellular materials intended for 
degradation to the lysosome, whereas the intracellular materials that need to be degraded 
are transported to the lysosome by the autophagy pathway (Settembre et al.). Lysosomes 
contain more than 50 acid hydrolases including proteases, peptidase, phosphatase, 
nucleases, glycosidases, sulfatases and lipases for the degradation of specific substrates 
(Luzio et al.; Bainton). 
In addition to cellular clearance, lysosomes are also involved in a secretory 
pathway known as exocytosis in which lysosomes secrete their contents by fusing with 
the plasma membrane (Chieregatti and Meldolesi; Verhage and Toonen). Some cells 
store newly synthesized secretory proteins in specialized lysosomal compartments. These 
organelles are known as secretory lysosomes or Lysosomes-Related Organelles (LROs) 
that include melanosomes, lytic granules, platelet-dense granules, Major 
Histocompatibility Complex (MHC) class II Compartments (MIIC), basophilic and 
azurophilic granules (Dell’Angelica et al.). These secretory lysosomes have cell-specific 
functions such as pigmentation, host defense, coagulation and both innate and adaptive 
immunity. The function of LROs varies depending upon the cell type. The size of these 
organelles is regulated by the rate of fusion of vesicles with the LRO and the rate of LRO 
fission, and many of the proteins that regulate these processes have been identified 
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(Dell’Angelica et al.; Perou, Leslie, et al.; Ward, Leslie and Kaplan; Ward et al.; 
Durchfort et al.). 
Most cells contain secretory lysosomes that are involved in the plasma membrane 
repair. Plasma membrane injury can be attributed to mechanical stress such as in muscles 
and skin or by pore-forming toxins from pathogens attempting to gain access to host cells 
(McNeil and Khakee; Gonzalez et al.). Cells must rapidly reseal their plasma membrane 
or suffer cell death and the lysosomes have been shown to play the critical role in this 
mechanism of the cell survival. 
Lysosomes play an important role in nutrient sensing and in signaling pathways 
that are important in cell metabolism and growth. Recently, lysosomes have been 
identified as signaling organelles that can sense nutrient availability and activate a 
lysosome-to-nucleus signaling pathway that mediates the starvation response and 
regulates energy metabolism. A master controller of cell and organism growth, the 
mammalian Target Of Rapamycin Complex1 (mTORC1), is a sensor of nutrient and 
growth factor levels that exerts its activity on the lysosomal surface. Hence, it controls 
the balance between biosynthetic and catabolic states. Under conditions such as 
starvation, infection, or oxidative stress, mTORC1 is inhibited and the cellular autophagy 
pathway is activated. Autophagy is a catabolic mechanism that involves the degradation 
and recycling of a cellular component for cell survival. mTORC1 inhibits autophagy in 
the presence of nutrients (Settembre et al.). 
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Diseases Associated with Lysosomal Dysfunction 
Lysosomes are involved in many cellular functions such as degradation of 
intracellular and extracellular materials, pigmentation, coagulation, wound repair, bone 
and tissue remodeling, pathogen defense, cell signaling and cell death (Saftig and 
Klumperman). Therefore, disturbances in lysosomal functions contribute to many 
diseases. For example, in the Lysosomal Storage Disease (LSD) Niemann-Pick the 
lysosomal substrate sphingolipid accumulates in the lysosome resulting in enlargement 
and lysosome dysfunction and can result in organism death. Other diseases such as 
Chediak-Higashi Syndrome (CHS), Gray Platelets Syndrome (GPS), Hermansky-Pudlak 
Syndrome (HPS) and Griscelli’s Syndrome also show an increase in the size of 
lysosomes and/or LROs, which affects normal function (Clark and Griffiths). CHS is the 
only one of these disorders that affects all LROs and lysosomes. GPS is an autosomal 
recessive bleeding disorder characterized by large platelets that lack alpha granules 
(Gunay-Aygun et al.). HPS is an autosomal recessive disease characterized by a partial 
albinism and bleeding tendencies resulting from the platelet dysfunction. These 
phenotypes are associated with the defects in the biogenesis of LROs, including 
melanosomes, platelet dense granules, lamellar bodies of type II alveolar epithelial cells 
and lytic granules of Cytotoxic T Lymphocytes (CTLs) and natural killer cells (Di Pietro 
and Dell'Angelica). Many of the genes responsible for HPS have been identified and they 
range from adaptor molecules to large multi-subunit complexes involved in LRO 
biogenesis (Clark and Griffiths). Griscelli Syndrome (GS) is a rare autosomal recessive 
disorder with patients showing characteristic pigment dilution of the skin and distinct 
silvery-grey hair; with the presence of large clumps of pigment in the hair shafts and an 
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abnormal accumulation of mature melanosomes in the center of melanocytes with 




Chediak-Higashi Syndrome (CHS) 
Chediak-Higashi syndrome (CHS) is a rare, autosomal recessive multisystem 
genetic disorder caused by mutations in the lysosomal trafficking regulator gene CHS1 
(Shiflett, Kaplan and Ward). CHS is characterized by severe immune deficiency, 
hypopigmentation, bleeding tendency, frequent bacterial infection, oculocutaneous 
albinism, and progressive neurological dysfunction (Spritz). The hallmark characteristic 
of CHS is the presence of giant cytoplasmic inclusion bodies and granules in all the cells 
of the body (Figure 1.1). The enlarged granules include lysosomes and LROs (Shiflett, 
Kaplan and Ward;  Introne, Boissy and Gahl; McVey Ward et al.). The beigej mouse, 
named after its beige coat color, has been the best-studied CHS model organism. Somatic 
cell fusions confirmed that the same gene was defective in beigej mice and CHS patients 
(Perou, Justice, et al.). The Lyst gene is localized on mouse chromosome 13 (Justice et 
al.) and the human CHS gene to position q42 on chromosome 1 (Barrat et al.; Fukai et 
al.). The Lyst gene in mice was identified using positional cloning and in vitro 
complementation using Yeast Artificial Chromosomes (YACs; Shiflett, Kaplan and 
Ward; Nagle et al.). The identification of the human CHS1 gene and CHS-associated 
mutations were subsequently identified by sequence analysis using the homology to a 




The Lyst gene encodes a ubiquitously expressed protein of approximately 3800 
amino acids. It is predicted to be a 430-kilodalton (kDa) cytosolic protein involved in 
lysosome size regulation. The amino acid sequence contains three to four defined 
domains including: an amino terminus HEAT (Huntington, Elongation factor 3, PR65/A, 
TOR) and ARM (Armadillo) domain containing α- helical repeats, a possible perilipin 
domain, a BEACH (Beige And Chediak) domain containing the amino acid sequence 
WIDL and WD40-repeats at the carboxyl terminus. The HEAT/ARM domains are 
predicted to be involved in vesicle trafficking (Andrade and Bork) and may function to 
mediate membrane interactions (Andrade et al.; Peifer, Berg and Reynolds). The perilipin 
domain may mediate interaction with lipids (Londos et al.). The conserved amino acid 
sequence WIDL domain (tryptophan (W), isoleucine (I), aspartic acid (D) and leucine 
(L)) has no known function and the WD40-repeats may serve as protein-protein 
interaction domains (Shiflett, Kaplan and Ward; Figure 1.2). WD-repeat proteins are 
involved in a variety of cellular functions such as cell cycle control, autophagy and 
apoptosis but the most noted function of WD-repeat proteins is vesicle trafficking 
(Cullinane, Schäffer and Huizing). Together the WIDL and WD40-repeat domains 
defined a family of protein called BEACH proteins (Shiflett, Kaplan and Ward; 
Cullinane, Schäffer and Huizing; Kaplan, De Domenico and Ward). 
Sequencing has shown that Lyst is a highly conserved protein in all eukaryotes 
(Shiflett, Kaplan and Ward) and some eukaryotes have several family members. 
Mammals have nine BEACH proteins and the slime mold Dictyostelium discoidium has 
six, Drosophila melanogaster and Arabidopsis thaliana have five BEACH proteins, 
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Caenorhabditis elegans has three BEACH proteins and Saccharomyces cerevisiae and 
Schizosaccharomyces pombe each have one BEACH protein (Shiflett, Kaplan and Ward). 
The nine mammalian BEACH (Figure 1.3) proteins include: Lyst, which is 
proposed to act as a scaffold protein that mediates fusion/fission events of vesicles in the 
endocytic pathway (Tchernev et al.); Neurobeachin (NBEA), which localizes to the trans-
Golgi of mammalian cells and binds to signaling complex Protein Kinase A (PKA) and 
plays a role in neuronal membrane trafficking (Wang et al.); Neurobeachin-like 
1(NBEA1), Neurobeachin-like 2(NBEA2), Lipopolysaccharide-Responsive Beige-like 
Anchor protein (LRBA), which is predicted to be important for host defense against 
infections and for cell proliferation; WD and FYVE zinc finger domain (FYVE domains 
mediate binding to phosphatidylinositol-3-phosphate, which regulates endocytic and 
autophagic membrane trafficking [Simonsen et al.]) containing protein 3(WDFY3) plays 
a role in clearance of neurologically related protein complexes; WD and FYVE zinc 
finger domain containing protein 4 (WDFY4) may have a significant role in autoimmune 
diseases (Yang et al.); Neutral Sphingomyelinase activation Associated Factor or Factor 
Associated Neutral sphingomyelinase (NSMAF or FAN), which is implicated in TNFR1-
mediated activation of NSMase and WD repeat domain 81 (WDR81), which is a 
transmembrane protein that when mutated results in recessive syndrome of quadrupedal 






Neutral Sphingomyelinase Activation Associated 
Factor (FAN or NSMAF) 
FAN is the smallest mammalian BEACH protein (948 amino acids) consisting of 
a short N-terminal segment followed by the BEACH and WD domains (Cullinane, 
Schäffer and Huizing). FAN has been shown to act in the Tumor Necrosis Factor (TNF) 
pathway. TNF is a cytokine primarily produced by activated macrophage that signals 
through two distinct cell surface receptors, 55 kDa (TNF-R55) and 75 kDa (TNF-R75). 
These receptors transmit signals to the cytoplasm and nucleus, which result in the 
activation of two major transcription factors, Nuclear Factor κB (NF-κB) and c-Jun. The 
activation of transcription factors results in the expression of genes important for several 
biological processes such as cell growth, cell death, development, oncogenesis, 
inflammation and stress responses (Krönke et al.; Tartaglia and Goeddel; Rothe et al.; 
Chen and Goeddel). Several studies have shown that both TNF-R55 and TNF-R75 are 
independently active in signaling the TNF response but the majority of TNF’s biological 
activities are initiated by TNF-R55 (Barbara et al.; Grell et al.; Gehr et al.; Tartaglia, 
Weber et al.; Espevik et al.; Tartaglia, Rothe, et al.; Wiegmann et al.). FAN interacts with 
the Neutral Sphingomyelinase activating Domain (NSD) of TNF-R55 upon ligand 
binding to activate Neutral Sphingomyelinase (NSMase) present at the plasma 
membrane. NSMase generates the lipid second messenger ceramide from sphingomyelin 
at the plasma membrane. The generated ceramide is involved in intracellular signaling 
including secretion of cytokines and growth factors and loss of organelle integrity 
(Adam-Klages et al.; Clarke and Hannun; Clarke et al.). There are three known NSMases 
and FAN has been associated with signaling through TNF-R55 in response to TNF 
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binding to activate NSMase2 (Wu, Clarke and Hannun; Kolesnick and Krönke). In 
addition to FAN’s role in NSMase activation, FAN has been shown to play a role in 
apoptosis (Ségui et al.; O’Brien et al.), actin reorganization in macrophages 
(Peppelenbosch et al.) and control of lysosome permeability (Werneburg et al.). FAN has 





A FAN-deficient mouse was generated to understand the role of FAN in 
activating NSMase. FAN-/- mice show defects in TNF-induced NSMase activation and 
also show a delay in cutaneous wound repair (Kreder et al.), which is a phenotype also 
associated with the loss of Lyst. Microscopic analysis shows that FAN-/- lysosomes are 
slightly enlarged (Figure 1.4), again similar to the loss of Lyst (Möhlig et al.). These 
phenotypes suggest that FAN plays a role in regulating the lysosome size. This could be a 
direct effect or FAN’s activation of NSMase at other vesicular locations may affect lipid 
content of those vesicles, membrane curvature, vesicular budding or fusion and thus 




FAN Binding Partners 
In the TNF-receptor pathway, NSMase2 is activated by TNF-R55 in response to 
TNF. The NSMase activation Domain (NSD) within the TNF-R55 serves as the binding 
site for FAN. FAN then recruits Receptor for Activated C-Kinase 1 (RACK1) and the 
nuclear Embryonic Ectoderm Development (EED) protein. In response to TNF binding at 
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the plasma membrane, EED translocate from the nucleus to the plasma membrane where 
it binds to nSMase2 and the TNF-R55-FAN-RACK1 complex inducing NSMase 
activation (Figure 1.5; Philipp et al.). 
RACK1 is a WD repeat protein that is highly conserved from Chlamydomonas to 
humans (Neer and Smith). It is a scaffolding protein, which interacts with several 
signaling pathways involved in the coordination of cell adhesion, movement, and division 
(Möhlig et al.). It also plays an important role in cell survival and in wound healing 
(McCahill et al.). RACK1 is a component of the eukaryotic ribosome and is involved in 
the recruitment of the ribosome to intracellular sites to regulate translation (Nilsson et 
al.). RACK1 binds to activate PKC (Protein Kinase C) isotypes and translocates to the 
cellular membranes preventing its premature degradation (Mochly-Rosen and Gordon). 
EED, a nuclear WD repeat protein of Polycomb group (Sewalt et al.), plays a role 
in lymphocyte proliferation, differentiation, organogenesis, and embryonic development. 
At the plasma membrane EED interacts with integrins, which are noncovalently 
associated heterodimeric cell surface adhesion molecules that mediate cell-cell, cell-
extracellular matrix, and cell-pathogens interaction. It also plays a vital role in leukocyte 
trafficking and migration, immunological synapse formation, costimulation, and 
phagocytosis (Witte et al.; Morin‐Kensicki et al.; Luo, Carman and Springer). 
A proteomic study identified FAN (NSMAF) as an Autophagy related 8 protein 
(Atg8) -interacting protein, a protein involved in regulating the closure of the 
autophagosome. That study also showed that small interfering RNA (siRNA) reductions 
in FAN resulted in a decreased autophagic flux. Those results suggest that FAN acts in 
regulating lysosome size by affecting autophagy and the reformation of lysosomes after 
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autophagy although a mechanistic role for FAN in autophagy remains to be elucidated 





The goal of this thesis is to characterize the roles of FAN and Lyst in lysosome 
homeostasis and lysosome size maintenance. 
The first aim is to determine if FAN and Lyst work in the same biochemical 
pathway to regulate lysosome size. Preliminary experimental data demonstrate that loss 
of either protein increases lysosome size and overexpression of either FAN or Lyst 
reduces lysosome size. 
The second aim is to identify the pathway and the partners that FAN might be 
working through to regulate the lysosome homeostasis and size. 
The approaches that will be used to address these questions include: the 
generation of a double knockout FAN-/-; beigej/beigej mouse to determine if FAN and 
Lyst are in the same or different pathways for regulating the size of lysosomes; inhibition 
of NSMase with specific NSMase inhibitor GW4869 to determine if NSMase activity 
affects lysosome size and if FAN requires NSMase activity to alter lysosome size; 
overexpression of epitope-tagged FAN to examine if there are changes in lysosome size 
and identify FAN partners; silencing of FAN binding partners using specific siRNA to 
determine the role of FAN binding partners in regulation of lysosome size; and lysosome 







Figure 1.1: Enlarged lysosomes in CHS patient fibroblasts 
Human fibroblast from HSFW11 (wild type) and GM02075 (CHS) patients were plated 
on glass coverslips. Cells were incubated with 5 µg/ml Texas red dextran (mw 10,000 da) 
at 37oC overnight, followed by a 2-hour chase to allow all dextran to localize to 
lysosomes. Images were captured on an Olympus BX51 microscope with a 60X, 1.4NA 








Figure 1.2: The Lyst protein 
A schematic representation of the Lyst protein containing ARM/HEAT repeats, a WIDL 
domain and a WD40-repeat domain. The Lyst protein contains 3801 amino acids. 







Figure 1.3: Mammalian BEACH family of proteins 






Figure 1.4: Enlarged lysosomes in beigej and FAN-/- mouse fibroblasts 
Fibroblasts from C57BL/6, beigej and FAN-/- mice were plated on glass coverslips. Cells 
were incubated with 5 µg/ml Texas red dextran (mw 10,000 da) at 37oC overnight, 
followed by a 2-hour chase to allow all dextran to localize to lysosomes. Images were 
captured on an Olympus BX51 microscope with a 60X, 1.4NA objective using Optronics 






Figure 1.5: FAN binding partners 
FAN binds to the NSD of TNFR1 in response to TNF binding. FAN binding recruits 
RACK1 and EED to induce NSMase activation. Adapted from (Philipp et al.). 
(PM, Plasma Membrane; TNF-R, Tumor Necrosis Factor Receptor; FAN, Factor 
Associated with Neutral Sphingomyelinase Activation; NSMase2, Neutral 







MATERIALS AND METHODS 
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Cells and Media 
Bone marrow cells were isolated from femurs of 6 to 8 week-old C57BL/6, beigej 
mice, or FAN-/- mice and seeded on 10-cm petri dishes. Macrophages were cultured in 
RPMI medium (Invitrogen, Carlsbad, CA), 2 mM L-glutamine, 20 µM b-
mercaptoethanol supplemented with 20% Fetal Bovine Serum (FBS) and 30% L-cell 
conditioned medium. Fibroblasts from mouse C57BL/6, beigej, FAN-/- or FAN-/-beigej, 
mouse NIH 3T3 fibroblast, HeLa, HEK293 and fro/fro fibroblast (obtained from Dr. 
Yusuf Hannun Medical University of South Carolina, Charleston, South Carolina) were 






FAN was cloned into pCMVTag2B (Agilent Technology, Santa Clara, CA) or 
pEGFP-C1 to generate an amino-terminally epitope-tagged FAN. Plasmid containing 
NSMase2 was a generous gift from Dr. Yusuf Hannun (Medical University of South 
Carolina, Charleston, South Carolina). Plasmids pcDNA 3.1(-) Myc-His A RACK1 and 






Cells were plated onto tissue culture plates and allowed to grow for 24 to 48 hours 
to 50-80% confluence. The cells were transfected with various constructs using Amaxa 
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Cells were treated with Non Specific (NS), EED, RACK1, NSMase1 and 
NSMase3 specific oligonucleotides (Dharmacon SiGenome SiRNA SMARTpool, 
Dharmacon RNA Technologies, Layfette, CO) using Oligofectamine Reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. About 150,000 
cells were treated with siRNA in Optimem reduced-serum medium (Invitrogen, Carlsbad, 
CA) for 6 hours at 37oC before serum-replete medium was added for overnight growth. 
Media was changed and cells were allowed to grow in DMEM with 10% FBS for 48 or 




mRNA Analysis by RT-PCR 
To isolate total RNA, cells were harvested as previously described following 
Qiagen RNeasy kit protocol. For the analysis, RT-PCR (Reverse Transcription-
Polymerase Reaction) was performed using specific primers and quantification was done 
using software Gel Doc XR+. Primers used: NSMase 1 (forward primer 5’ 
CGTGCTTTACAAGGCAGTTTCTGG 3’ and reverse primer 5’ 
CTCTCTGCTGGTCCGTGGGTA 3’), NSMase 3 (forward primer 
5’GTACCAGATCATCAATGGGCTG 3’ and reverse primer 
5’CTGTCCTGCAAATCTGTGGTTG 3’), EED (forward primer 
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5’AGACGAGAATGATGACGCTGTTCAG 3’and reverse primer 
5’CAAGGTAACTCTGTTGCTTCCTAC 3’) and RACK1 (forward primer 
5’GGGACAAGCTGGTCAAGGTA 3’ and reverse primer 
5’GGGATCCATCTGGAGAGACA 3’). The RT- PCR was performed with an initial 
synthesis of cDNA at 60oC for 30 minutes followed by denaturation of DNA at 94oC for 
2 minutes, then 40 cycles of 94oC for 30 seconds and 55oC for 30 seconds and 68oC for 





Cells were plated onto 1 mm x 18mm glass coverslips in the respective growth 
medium, incubated at 37ºC with 5 µg/ml Alexa 488- or Alexa 594-dextran (mw 10,000) 
(Invitrogen, Carlsbad, CA) overnight followed by a 2-hours chase to allow all dextran to 
localize to lysosomes. Images were captured on an Olympus BX51 microscope with a 
60X, 1.4NA lens using Optronics Picture Frame software (Olympus Inc., Melville, NY). 
For immunofluorescence analysis, cells plated on glass coverslips were fixed in 3.7% 
formaldehyde (Sigma-Aldrich, St. Louis, MO) in Phosphate Buffered Saline (PBS) for 20 
minutes at room temperature. Cells were washed in PBS, permeabilized with 0.01% 
Saponin/PBS/1% Bovine Serum Albumin (BSA) and incubated with 1:100 rat anti-
Lamp1, 1:100 rabbit anti-myc, 1:250 rabbit anti-flag followed by 1:750 Alexa 488 or 
Alexa 594 conjugated goat anti-rat IgG, Alexa 594 goat anti-mouse IgG, Alexa 488 
conjugated goat anti-rabbit IgG. Quantifications of lysosome size were done on 
epifluorescent images using greater than 20 fields per cell type with 2-5 cells per field. 
Measurements of lysosome diameter were performed using NIH Image J software 
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Neutral Sphingomyelinase Inhibition 
NSMase effect on lysosome size regulation was studied by treating cells with 
NSMase inhibitors GW4869 (Cayman Chemicals, Ann Arbor, MI) or 3-O-
Methylsphingomyelin at a concentration of 5 µM for 24-hours or for different interval of 
time, and lysosome size was measured by live cell microscopy as previously described 




Neutral Sphingomyelinase Activity Assay (14C Assay) 
Wild type C57BL/6 and fro/fro fibroblasts were plated onto 100 mm tissues 
culture plates and allowed to grow for 24 to 48 hours to 50-80% confluence. The cells 
were lysed in lysis buffer plus 2X protease inhibitor cocktail (Roche Applied Science, 
Boulder, CO), sonicated and centrifuged at 500 x g at 4’C for 10 minutes and the 
supernatant was transferred to a new eppendorf. Protein determinations were performed 
and samples (150-300 µg/reaction) in 100 µl of lysis buffer were prepared. The reaction 
was started by adding 100 µl of reaction mixture (200 µM Sphingomylein, 100 µM 
phosphatidylserine, 200 mM Tris, pH 7.4, 10 mM MgCl2 0.2 % Triton X100, 5mM 
Dithiothreitol (DTT), Roche EDTA- free tablet) containing 14C-sphingomyelin to the cell 
lysate, mixed by vortexing and then incubated at 37oC for 120 minutes. The reaction was 
stop by adding 1.5 ml chloroform/methanol (2:1), 0.4 ml of water and vortexed for 15 
seconds. The mixture was centrifuged at 2000 x g for 5 minutes at room temperature, the 
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upper aqueous phase transferred to scintillation vials containing 10 ml of scintillation 





Bone marrow-derived macrophages were cultured from femurs of C57BL/6, 
beigej, and FAN-/- mice. Cells were washed in ice-cold PBS, scraped and centrifuged at 
200 x g at 4’C for 5 minutes. Lipidomic analysis was performed using an Agilent 1290 
Infinity LC system coupled to an Agilent 6520 Quadrupole Accurate-Mass Q-TOF LC-
MS instrument equipped with an Acquity UPLC CSH C18 (100 x 2.1 mm; 1.7 um) 
column. The gradient starts at 15% mobile phase B then increases to 30% B over 4 
minutes, it then increases to 52% B from 4-5 minutes, then increases to 82% B from 5-22 
minutes, then increases to 95% B from 22-23 minutes, then increases to 99% B from 23-
27 minutes. From 27-38 minutes it is held at 99% B, then decreases to 15% B from 38-
38.2 minutes and is held there from 38.2-44 minutes. Flow is 0.3 mL/min throughout. 
Mobile phase A consists of ACN: water (60:40 v/v) in 10mM ammonium formate and 
0.1% formic acid, and mobile phase B consists of IPA: water (90:10 v/v) in 10mM 
ammonium formate and 0.1% formic acid. The column temperature was set to 65oC. 
Acquisition was performed in positive and negative ESI mode acquiring from m/z 100-
1700. The mass spectrometer was operated using the following parameters while in 
positive mode: dry gas temperature, 350oC; dry gas flow, 11.1 L/min; nebulizer pressure, 
24 psig; Vcap, 5000V; fragmentor, 250 V; skimmer 74.4 V; sample injection, 3 µL. The 
mass spectrometer was operated using the following parameters while in negative mode: 
dry gas temperature, 260oC; dry gas flow, 8.6 L/min; nebulizer pressure, 21 psig; Vcap, 
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5000V; fragmentor, 100 V; skimmer 75 V; sample injection, 5 µL. Tandem mass 











Generation of FAN-/-/beigej Mouse 
FAN-/- mice were crossed with beigej mice and bred to homozygosity (FAN-/-; 
beigej/beigej). The absence of Lyst results in a coat color defect but the absence of FAN 
was not appreciated to alter the C57BL/6 color. The loss of both Lyst and FAN is 
additive in affecting coat color (Figure 3.1) and at the cellular level the loss of both FAN 
and Lyst results in an additive effect on altering lysosomes size (Figure 3.2). These 





Inhibition of NSMase Activity 
FAN has been shown to interact with TNFR1 to activate NSMase2 at the plasma 
membrane. To determine if the level of NSMase affects steady state lysosome size, cells 
were incubated with the specific NSMase inhibitor GW4869 or 3-O-
Methylsphingomyelin and the lysosome morphology was examined by fluorescence live-
cell microscopy. Microscopic analyses showed that inhibition with GW4869 (Figure 3.3) 
or 3-O-Methylsphingomyelin gave rise to enlarged lysosomes (Figure 3.4). These results 




Overexpression of NSMase2 
To determine if NSMase2 levels are limiting in regulating lysosome size, 
NSMase2-GFP under a CMV promoter was transfected into HeLa cells and the size of 
lysosomes assessed using epifluorescence microscopy. No changes in lysosome size were 
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observed when NSMase2-GFP was overexpressed in the cell (Figure 3.5). Previous 
studies demonstrated no change in lysosome size when NSMase2-GFP was 
overexpressed in either FAN-/-, or beigej fibroblasts (Durchfort). This result demonstrates 
that increased levels of NSMase2 do not affect lysosome size. We did note that a fraction 
of NSMase2-GFP could be found coincident with lysosomes. This could be an effect of 




Overexpression of FAN 
Previous studies demonstrated that overexpression of Lyst gave rise to small 
lysosomes localized to the periphery of cells (Perou, Leslie, et al.). To determine if 
overexpression of FAN would have a similar affect a construct containing epitope-tagged 
(GFP) mouse FAN expressed under the control of the CMV promoter was generated and 
transfected into C57BL/6, FAN-/-, or beigej fibroblasts. Transfected cells were incubated 
with 5 µg/ml Texas red dextran overnight, chased in growth media for 2 hours and 
lysosome morphology assessed using epifluorescence microscopy. Overexpression of 
GFP-FAN reduced lysosome size in wild type and FAN-/- cells but not in beigej cells 
(Figure 3.6). The reduction in lysosome size seen in FAN-overexpressing cells was 
prevented by the addition of the NSMase inhibitor GW4869 (Figure 3.7). 
The characterization of FAN as an activator of NSMase identified NSMase2 as 
the activated NSMase (Philipp et al.). To determine if FAN is acting through NSMase2 to 
alter lysosome morphology we obtained fibroblasts from the fro/fro mouse, which 
harbors a deletion mutation, that blocks expression of NSMase2 (Khavandgar et al.) and 
examined lysosome morphology and whether or not FAN overexpression altered 
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lysosome morphology in the absence of NSMase2. No changes in lysosome size, 
distribution, or morphology were observed in fro/fro cells compared to wild type 
C57BL/6 fibroblasts. Additionally, the reduction in the lysosome size seen when FAN 
was overexpressed was still observed in fro/fro cells (Figure 3.8). We confirmed that the 
fro/fro mouse fibroblast showed less neutral sphingomyelinase activity compared to the 
wild type C57BL/6 cells (Figure 3.9). Together, these results demonstrate that like Lyst, 
FAN overexpression reduces lysosome size and that the absence of NSMase2 does not 




RNA Interference of NSMase1 and NSMase3 
To determine if FAN is working through other NSMases, RNAi was used to try to 
reduce the levels of NSMase1 and NSMase3. No alteration in lysosome morphology was 
observed in NSMase1 and NSMase3 RNAi-treated cells (data not shown). Analysis of 
mRNA levels was done by RT-PCR. The result showed a 58% reduction of NSMase1 
mRNA, however, no reduction of NSMase3 mRNA level was observed (Figure 3.10). 
These results suggest that reduced level of NSMase1 does not alter lysosome 
morphology; however, a 58% reduction in NSMase1 mRNA may not be sufficient to 
produce an effect. Further studies are needed to reduce NSMase1 and NSMase3 levels 
and then analyze the lysosome phenotype in absence of FAN in order to determine if 





Overexpression and RNA Interference of FAN Binding Partners 
FAN has been shown to interact with RACK1 to activate NSMase (Möhlig et al.). 
This activation is dependent upon RACK1 binding to the polycomb protein EED (Philipp 
et al.). To determine if FAN binding partners RACK1 or EED play a role in regulating 
the lysosome size, epitope-tagged RACK1 or EED was overexpressed and lysosome size 
assessed. No changes in lysosome size or morphology were observed with either RACK1 
(Figure 3.11) or EED overexpression (Figure 3.12). We did note that a fraction of 
RACK1-myc could be found coincident with lysosomes. This could be an effect of 
overexpression or this may indicate that RACK1 has a function at lysosomes.  
RNA interference was used to knockdown RACK1 or EED levels in cells. mRNA 
analyses by RT-PCR showed a 57.5% reduction of EED mRNA and 37.79% reduction in 
RACK1 mRNA (Figures 3.13, 3.14). Further experiments are needed to improve the 
RNAi efficiency and once better “silencing” is obtained lysosome size will be assessed to 





As changes in cellular lipid content can alter lysosome size (Sbrissa et al.; 
Mukherjee and Maxfield), we postulated that changes in lysosome size could be 
attributed to alterations in the lipid composition and that the absence of Lyst or FAN may 
results in changes in lipid profiles. We isolated bone marrow-derived macrophages of 
C57BL/6, beigej and FAN-/- mice. Cells were then subject to lipidomic analyses using 
tandem LC-MS. Little difference in lipids was observed between beigej and C57BL/6 
cells but significant changes were observed when comparing C57BL/6 to FAN-/- (Table 
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3.1). Principle Components Analysis (PCA) between C57BL/6 and FAN-/- lipids showed 
greater than 20 altered lipids (Figure 3.15). Further analysis showed that 15 different lipid 
were significantly changed in the absence of FAN (Figure 3.16). The identities of some 
of these lipids are known and suggest that the levels of free fatty acids and possible 
ceramides were significantly decreased in the absence of FAN. These results show that 







Figure 3.1: Coat color difference between C57BL/6, beigej, FAN-/-, FAN-/-/ beigej 
mice 
The beigej mouse has a lighter coat color compared to C57BL/6. The absence of FAN 
does not show an alteration in coat color, whereas the beigej coat color defect was 






Figure 3.2: The absence of FAN and Lyst results in enlarged lysosomes 
Fibroblast from C57BL/6, beigej, FAN-/-, FAN-/-/ beigej mice were plated on glass 
coverslips and incubated with 5 µg/ml Texas red dextran (mw 10,000 da) at 37oC 
overnight, followed by a 2-hour chase to allow all dextran to localize to lysosomes. 
Images were captured on an Olympus BX51 microscope with a 60X, 1.4NA objective 
using Optronics Picture Frame software (Olympus Inc., Melville, NY). 






Figure 3.3: NSMase inhibition induces an increase in lysosome size 
C57BL/6 cells were plated on glass coverslips and incubated with 5 µg/ml Texas red 
dextran (mw 10,000 da) at 37oC overnight, followed by a 2-hour chase to allow all 
dextran to localize to lysosomes. Five µM NSMase inhibitor GW4869 was added and 
incubated at 37oC overnight. Images were captured on an Olympus BX51 microscope 











Figure 3.4: Time-dependent effect of NSMase inhibitor 3-O-Methylsphingomyelin 
on lysosome size 
C57BL/6 cells were plated on glass coverslips and incubated with 5 µg/ml Texas red 
dextran (mw 10,000 da) at 37oC overnight, followed by a 2-hour chase to allow all 
dextran to localize to lysosomes. Cells were then incubated with 5 µM NSMase inhibitor 
3-O-Methylsphingomyelin at 37oC for different time interval and images were captured 
on an Olympus BX51 microscope with a 60X, 1.4NA objective using Optronics Picture 
Frame software (Olympus Inc., Melville, NY). Measurement of lysosome size was done 































Figure 3.5: NSMase2 overexpression does not alter lysosome size 
HeLa cells were transfected with the plasmid pCMV NSMase2-GFP. Cells were plated 
on glass coverslips and incubated with 5 µg/ml Texas red dextran (mw 10,000 da) at 
37oC overnight, followed by a 2-hour chase to allow all dextran to localize to lysosomes. 
Images were captured on an Olympus BX51 microscope with a 60X, 1.4NA objective 
using Optronics Picture Frame software (Olympus Inc., Melville, NY). The arrow 
denotes the area blown up as an insert showing colocalization of NSMase2 on Texas red 
dextran loaded lysosomes.
HeLa 












Figure 3.6: FAN overexpression does not reduce lysosome size in the absence of Lyst 
C57BL/6, FAN-/-, beigej cells were transfected with the plasmid pEGFP-FAN. Cells were 
plated on glass coverslips and incubated with 5 µg/ml Texas red dextran (mw 10,000 da) 
at 37oC overnight, followed by a 2-hour chase to allow all dextran to localize to 
lysosomes. Images were captured on an Olympus BX51 microscope with a 60X, 1.4NA 
objective using Optronics Picture Frame software (Olympus Inc., Melville, NY). Arrows 












Figure 3.7: Inhibition of NSMase blocks the reduction in lysosome size in cells 
overexpressing FAN 
NIH3T3 fibroblasts were transfected with the plasmid pEGFP-FAN. Cells were plated on 
glass coverslips and incubated with 5 µg/ml Texas red dextran (mw 10,000 da) followed 
by a 2-hour chase to allow all dextran to localize to lysosomes. Cells were then incubated 
with 5 µM NSMase inhibitor GW4869 at 37oC overnight. Images were captured on an 
Olympus BX51 microscope with a 60X, 1.4NA lens using Optronics Picture Frame 
software (Olympus Inc., Melville, NY). Measurement of lysosome size was done on 
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Figure 3.8: The absence of NSMase2 does not affect lysosome size or the FAN-
mediated reduction in lysosome size 
Fibroblast WT, fro/fro (NSMase2 deficient cell), fro/fro (NSMase2 deficient cell) 
transfected with pEGFP-FAN were plated on glass coverslips and incubated with 5 µg/ml 
Texas red dextran (mw 10,000 da) followed by a 2-hour chase to allow all dextran to 
localize to lysosomes. Images were captured on an Olympus BX51 microscope with a 
60X, 1.4NA objective using Optronics Picture Frame software (Olympus Inc., Melville, 
NY). Arrows denote GFP-FAN overexpressing cells with small lysosomes and the 
arrowheads denote an untransfected cell in the same culture with larger lysosomes. 





Figure 3.9: fro/fro cells exhibit decreased NSMase activity in vitro 
Neutral sphingomyelinase activity was measured in WT and fro/fro cells according to the 




































Figure 3.10: mRNA analysis of NSMase1 and NSMAse3 by RT-PCR 
HeLa cells were treated with Non Specific (NS), NSMase1 or NSMase3 specific 
oligonucleotides for 72 hours, RNA isolated and analyzed by RT-PCR. mRNA was 











































Figure 3.11: RACK1 overexpression does not alter lysosome size 
NIH3T3 fibroblast was transfected with the plasmid pCMV RACK1-myc and grown on 
glass coverslips overnight followed by fixation in formaldehyde. Lamp-1 and RACK1-
myc were localized by immunofluorescence microscopy using a rat anti-Lamp-1 antibody 
and rabbit anti-myc followed by Alexa 594 conjugated goat anti-rat IgG and Alexa 488 
conjugated goat anti-rabbit IgG. Images were captured on an Olympus BX51 microscope 
with a 60X, 1.4NA objective using Optronics Picture Frame software (Olympus Inc., 
Melville, NY). The arrow denotes the “blown-up” area showing colocalization of 
RACK1-myc on Lamp-1 positive lysosomes.









Figure 3.12: EED overexpression does not affect lysosome size 
HeLa cells were transfected with the plasmid pCMV FLAG-EED. Cells were plated on 
glass coverslips and fixed in formaldehyde. Lamp-1 and FLAG-EED were localized by 
immunofluorescence microscopy using a mouse anti-Lamp-1 antibody and rabbit anti-
flag followed by Alexa 594 conjugated goat anti-mouse IgG and Alexa 488 conjugated 
goat anti-rabbit IgG. Images were captured on an Olympus BX51 microscope with a 









Figure 3.13: mRNA analysis of EED by RT-PCR 
HeLa cells were treated with either Non Specific (NS) or EED specific oligonucleotides 
for 72 hours, RNA isolated and analyzed by RT-PCR. mRNA was normalized to actin. 










































Figure 3.14: mRNA analysis of RACK1 by RT-PCR  
HEK293 cells were treated with either Non Specific (NS) or RACK1 specific 
oligonucleotides for 72 hours, RNA isolated and analyzed by RT-PCR. mRNA was 





































RNAi 72 hours 
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Table 3.1: List of altered cellular lipids in beigej or FAN -/- macrophages 
LC-MS lipidomic analysis of cellular lipids from C57BL/6 vs beigej, or C57BL/6 vs 
FAN-/-. Putative alter lipids were analyzed using Mass Hunter Quant to eliminate false 
positives. Altered lipid metabolites are highlighted in red. Yellow highlights show higher 
level of lipid in either beigej or FAN-/- samples and green highlights show lower level of 
change in lipid. Red highlights p values below 0.05.  Few alterations were observed 
between the beigej and C57BL/6 samples. 
 
Name Possible ID's Fold Change beigej Vs C57BL/6 
p-value beigej Vs 
C57BL/6 
Fold Change FAN -/- 
Vs C57BL/6 
p-value FAN -/- Vs 
C57BL/6 
            
497.3823_1.089905
5  unknown 2.965164018 0.035581594 2.227001955 0.05946134 
272.2343_4.685147  2-hydroxy palmitic acid 0.543375214 0.196797837 0.120965879 0.040404999 
440.3061_5.985808
4  unknown 0.718325744 0.252121994 0.261214751 0.025732393 
582.4651_7.052325  unknown 0.586911324 0.22148379 0.123411971 0.041186971 
530.4318_7.085412
5  unknown 0.701554305 0.377051824 0.061410521 0.042772567 
254.2242_7.096673
5  palmitoleic acid 0.533319935 0.084116867 0.126270375 0.01320699 
555.3902_7.488754  unknown 0.701615535 0.377104854 0.067759424 0.04353791 
268.24_7.9912376:








1.037180412 0.782154655 0.354811296 0.001611473 
422.2799_9.004133  PA(P-18:0/0:0) 0.570409909 0.077173726 0.177512544 0.013677897 
282.2554_9.012176  oleic acid 0.716790716 0.199110021 0.279827659 0.021379078 
1186.9279_8.99351  unknown 0.606083804 0.117015354 0.134065964 0.012379705 
326.1919_9.008625  unknown 0.666354991 0.078422385 0.244995702 0.007237286 









4.906910634 0.101371602 2.87566406 0.034133479 
366.3495_16.36675





Figure 3.15: PCA analysis of C57BL/6, beigej and FAN-/- 
A. PCA plot of C57BL/6 (blue), beigej (red) and FAN -/-(brown) shows clear class 
separation. 
B. PCA plot of FAN -/- versus C57BL/6. Class separation is observed primarily in the 
first component.





Figure 3.16: Volcano plot of FAN-/- vs. C57BL/6 
The volcano plot derived from these data with 23 possibly altered lipids indicated by red 










Loss of Lyst and FAN Shows an Additive Effect 
on Altering Lysosome Size 
Lyst and FAN proteins belong to the conserved BEACH family. The loss of either 
Lyst or FAN gives rise to enlarged lysosomes and a defect in cutaneous barrier repair 
(Möhlig et al.). The biochemical pathway for regulating lysosome size is not known for 
Lyst or FAN. To learn more about the biochemical pathway in regulating the size of the 
lysosome by Lyst and FAN, FAN-/- mice were crossed with beigej mice and bred to 
homozygosity (FAN-/-;beigej/beigej). Notably, loss of both FAN and Lyst exacerbates the 
enlarged lysosome phenotype seen in either single deletion. Further, the pigmentation 
defect seen in the beigej mouse was exacerbated by the loss of FAN. This is the first 
report that FAN may be involved in regulating LRO size or biogenesis and provides 
genetic evidence that Lyst and FAN work in different pathways to regulate LRO size. 
These results also suggest that there are at least two biochemical pathways involved in 




Effect of NSMase Activity on Lysosome Size 
FAN binds to the TNF receptor and signals the activation of NSMase, which 
generates phosphocholine and ceramide. NSMases are found at the plasma membrane 
and other organelles including lysosomes. The cytosolic protein FAN interacts with the 
TNF receptor at the plasma membrane in response to ligand binding and activates 
NSMase2 (Philipp et al.). Overexpression of NSMase2 does not affect TNFR-mediated 
signaling. We determined that there were no changes in lysosome size in NSMase2 
overexpressing cells, suggesting that NSMase activity is also possibly regulated at the 
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lysosome. Controlling the activity of NSMase on different membranes allows for 
localizing signaling and possibly regulating the amount of signal. Further, this suggests 
that molecules that regulate NSMase activity may act at different membranes and that 
FAN, an activator of NSMase (Adam-Klages et al.), might be rate limiting for regulating 
the lysosome size. In support of this hypothesis, we observed that inhibition of all 
NSMases with the specific NSMase inhibitor GW4869 or 3-O-Methylsphingomyelin 
gave rise to a time dependent enlargement of lysosomes. These results support a role for 




Role of FAN in Regulation of Lysosome Size 
Previous studies have shown that Lyst is limiting for regulating lysosomes size 
(Perou, Justice, et al.). That is, overexpression of Lyst gives rise to smaller than normal 
lysosomes. In the current study, we determined that increasing FAN levels also reduces 
lysosome size. Overexpression of FAN, however, did not reduce the size of lysosomes in 
the absence of Lyst. Since the loss of both Lyst and FAN is additive in affecting the 
enlarged size of lysosomes supporting two pathways, that overexpression of FAN in the 
absence of Lyst does not reduce lysosome size may reflect the absence of a factor 
necessary for FAN function. What that factor may be still needs to be elucidated. 
The regulation of lysosome size can be mediated by fusion or fission events. 
Studies have suggested that Lyst is a negative regulator of fusion (Harris et al.) or a 
positive regulator of fission (Durchfort et al.). How FAN acts to regulate lysosome size 
has not been investigated. Our studies suggest that FAN acts to activate NSMases, 
perhaps at the lysosome but possibly at an earlier compartment. Activation of NSMase 
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would result in the localized generation of ceramide. Increased levels of ceramide at an 
endosomal/lysosomal membrane would be predicted to cause changes in the curvature of 
the lipid bilayer. A role for NSMase2 at the Multivesicular Body (MVB) has been 
suggested to drive inward membrane budding (Mittelbrunn and Sánchez-Madrid), and a 
defect in this pathway could lead to enlarged late endosomes fusing with lysosomes and 
thereby resulting in an enlarged lysosome. FAN could be acting to control NSMase 
activity at the MVB. fro/fro cells, however, do not show enlarged lysosomes. As 
demonstrated, FAN overexpression reduces lysosome size even in the absence of 
NSMase2. Other NSMases may compensate for the loss of NSMase2. Our RNAi 
experiments have not ruled out the possibility that FAN works through another NSMase. 
Future studies will be focused on efficiently reducing the levels of NSMase1 and 3 and 
then looking at the effects of FAN overexpression. We will also examine if FAN is 




Overexpression and RNA Interference of FAN Binding Partners 
In the TNF-receptor pathway, NSMase2 is activated by TNF-R55 in response to 
TNF. The NSD within the TNF-R55 serves as the binding site for FAN, which recruits 
RACK1 and the nuclear EED protein (Philipp et al.). Our studies demonstrate that 
overexpression of RACK1 or EED did not affect lysosome size. We did note that a small 
fraction of RACK1 localized on lysosomes, so it is possible that RACK1 may play a role 
in regulating lysosome size. EED was seen predominantly in the nucleus as expected 
(Philipp et al.). Our preliminary RNAi experiments for RACK1 and EED, which showed 
about 50% reduction in mRNA, suggest that we may be able to reduce the levels of these 
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proteins sufficiently to determine if they play a role in FAN-mediated reductions in 
lysosome size. It should be noted, however, that the absence of RACK1 or EED is 
embryonic lethal (Volta et al.; Schumacher, Faust and Magnuson) and results of efficient 
silencing and examination of lysosome morphology changes must be analyzed with care 




The Absence of FAN Alters the Lipid Profile 
One possible explanation for changes in lysosome size when FAN is 
overexpressed or absent is that there is a change in the lipid composition. We performed 
lipidomic profiling using LC-MS and MS-MS analysis on wild type C57BL/6, beigej and 
FAN-/- cells to determine if the absence of Lyst or FAN alters cellular lipid content. 
Lipidomic analysis demonstrated a strong difference between C57BL/6 and FAN-/- 
samples but very little difference between beigej and C57BL/6 samples. The 
identification of the metabolites found was difficult. Free fatty acids like 2-hydroxy 
palmitic acid, palmitoleic acid, oleic acid, 24:1 fatty acid, margaric acid and 
nonadecanoic acid were all decreased in the FAN-/- samples. In addition to free fatty acid 
alterations, a number of possible ceramides were also decreased in the FAN-/- samples but 
their identity is not known. These results demonstrate that the absence of FAN alters lipid 
composition and leaves open the question of whether or not these changes would result in 
alterations in lysosome size. Future lipidomic analysis will be performed on lysosomes 
isolated from wild type C57BL/6, beigej and FAN-/- cells. These studies will allow us to 





Lyst and FAN proteins belong to the conserved BEACH family. Loss of either 
Lyst or FAN gives rise to enlarged lysosome. Generation of a beigej/FAN-/- mouse 
supports a role of FAN in LRO homeostasis and that the loss of both proteins is additive. 
The enlarged lysosome size observed in the beigej/FAN-/- mouse suggests that there are at 
least two biochemical pathways involved in regulating lysosome size. The 
overexpression of FAN in absence of Lyst did not correct the size of lysosome. 
FAN binds to the TNF receptor and signals the activation of NSMase. The 
NSMase are found at the plasma membrane and on other organelles including lysosomes. 
Inhibition of NSMase with the specific NSMase inhibitor GW4869 or 3-O-
Methylsphingomyelin resulted in enlarged lysosome. The overexpression of FAN 
resulted in the reduction of lysosome size but the overexpression phenotype was blocked 
by the addition of the NSMase inhibitor GW4869. This suggests that the FAN is working 
through an NSMase to decrease lysosome size. 
The role of FAN-binding partners RACK1 and EED in regulating the lysosome 
morphology is not resolved and future experiments are necessary to determine if they 
play a role in regulating lysosome size. 
The activation of NSMases is predicted to change the lipid composition of cells. 
Lipidomic profiling using LC-MS and MS-MS analysis of C57BL/6 and FAN-/- cells 
showed that the levels of free fatty acids and ceramides were significantly decreased in 
FAN-/- cells. Future studies will examine if these changes are also reflected on the lipid 
composition of lysosomes. Changes in cellular lipid composition in the FAN-/- cells may  
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also alter other membrane trafficking events. Future studies may inform whether there are 




























Lysosomes are membrane bound organelles that contain hydrolases capable of 
degrading proteins, lipids and carbohydrates. They are involved in nutrient sensing and 
storage and retrieval. Lysosomes are highly dynamic and are capable of fusion and 
fission events with other organelles and plasma membranes. Higher eukaryotes possess a 
specialized group of lysosomes termed secretory lysosomes that are involved in 
pigmentation, coagulation, wound repair and immunologic functions. Understanding the 
molecular machinery that regulates lysosome and secretory lysosome homeostasis is 
underscored by the fact that mutations in the genes that regulate the biogenesis, 






Lysosomes were first described by Dr. Christian de Duve in 1955 as the major 
degradative compartment within eukaryotic cells (Appelmans, Wattiaux and De Duve). 
Structurally they appear as dense bodies that often are found associated with the 
Microtubule-Organizing Center (MTOC) near the nucleus of the cell. They can vary in 
size, shape and number depending upon the cell type. Recently, the quantity of lysosomes 
was found to be regulated by the Transcription Factor EB (TFEB) (Sardiello et al.). 
TFEB recognizes a DNA sequence (GTCACGTGAC) termed coordinated lysosomal 
expression and regulation or CLEAR sequence found in many genes that encode for 
lysosomal proteins (Settembre et al.). TFEB controls the biogenesis of lysosomal 
hydrolases and membrane proteins. It exists in the cytosol and under altered lysosomal 
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conditions such as nutrient starvation or hyperaccumulation of substrates, TFEB 
translocates to the nucleus to activate lysosome biogenesis gene transcription, thus 
generating increased numbers of lysosomes. Lysosomes possess an acidic lumen 
containing many types of hydrolases responsible for the degradation of substrates. The 
high H+ content is driven by the presence of the vacuolar ATPase H+ pump. Lysosomes 
also contain high levels of calcium (Ghislat and Knecht), second in amount compared to 
the ER. The lysosomal membrane contains highly glycosylated proteins including 
Lysosome-Associated Membrane Proteins (LAMPs) and Lysosomal Integral Membrane 
Proteins (LIMPs). This high level of glycosylation is thought to protect the proteins from 
the degradative enzymes stored in lysosomes. Cytosolic facing lysosomal proteins are 
involved in regulating the transport of material to and from the lysosome (Saftig and 
Klumperman; Luzio, Hackmann, et al.). Transport to the lysosome is primarily achieved 
through vesicular delivery of endocytosed or phagocytosed material. Along this delivery 
pathway to the lysosome, lipids and proteins can be recycled from endosomal 
compartments or they can be targeted to lysosomes for degradation. Lysosomes can also 
obtain cytosolic components such as proteins, lipids and organelles destined for 
degradation through regulated autophagy (Schneider and Cuervo; Parzych and Klionsky). 
The digestive nature of lysosomes allows for the reuse of amino acids and lipids as 
building “material” for generating new nucleic acids, proteins, lipids, and organelles. 
Along with their degradative functions, specialized lysosomes termed Lysosome-
Related Organelles (LROs) or secretory lysosomes can be found in most cells types. 
Examples of secretory lysosomes include melanosomes, lytic granules, platelet-dense 
granules and Major Histocompatibility Complex class II (MHCII) compartments. They 
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share many properties of lysosomes but also have cell-specific functions such as 
pigmentation, host defense, coagulation, and innate and adaptive immunity. This review 
will focus on the characteristics of lysosomes and cell-specific secretory lysosomes, their 
biogenesis and functions, including an emphasis on the importance of conventional and 





All eukaryotes possess organelles that are ascribed to have lysosomal functions, 
the storage and degradation of molecules. In plants and fungi such as the model organism 
Saccharomyces cerevisiae, lysosomes are called vacuoles. Much of what is know about 
lysosome biogenesis and delivery to lysosomes can be attributed to the exquisite genetic 
studies done in yeast (Schekman; Rothman et al.; Klionsky, Herman and Emr; Bryant and 
Stevens; Wickner; Wickner and Haas; Efe, Botelho and Emr). Historically, the lysosomal 
compartment has been considered to be an endpoint organelle and many reviews on the 
endocytic system still depict this organelle as an endpoint. Over the past 20 years it has 
been appreciated that this organelle is not the endpoint of the endocytic pathway but 
rather is another membrane compartment where sorting occurs, pathogens can be 
degraded or persist, signaling can be initiated and energy metabolism can be assessed 
(Luzio, Hackmann, et al.; Borlace et al.; Barrias, de Carvalho and De Souza; Baxt, Garza-
Mayers and Goldberg; Settembre et al.). Lysosomes and secretory lysosomes can be 
distinguished from late endosomes by the absence of Mannose-6-Phosphate Receptors 
(M6PR; Brown, Goodhouse and Farquhar), receptors responsible for the delivery of 
lysosomal hydrolases to the developing lysosome. The delivery of molecules to 
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lysosomes can be mediated either by transport vesicles from the Trans-Golgi Network 
(TGN) fusing with late endosomes followed by the recycling of components required for 
further rounds of delivery from the TGN or by direct delivery of LAMPs from the TGN 
to lysosomes through an Adaptor Protein (AP). This AP-mediated delivery provides a 
mechanism for coated vesicles to sort cargo specific for lysosomal delivery. The delivery 
of molecules from late endosomes to lysosome was coined “kiss-and-run,” in which late 
endosomes briefly fuse with lysosomes. It forms a hybrid organelle that fissions, 
reforming lysosomes and recycling late endocytic vesicles (Bright et al.; Luzio, Pryor and 
Bright; Luzio, Pryor, et al.; Luzio, Rous, et al.; Mullock et al.). Biochemical and 
microscopic evidence has also shown that lysosomes are capable of fusing with other 
lysosomes (homotypic fusion) and they can subsequently fission (Patterson and 
Lippincott-Schwartz; Ward, Leslie and Kaplan; Ward et al.; Durchfort et al.; Perou, 
Leslie, et al.; Michaillat, Baars and Mayer; Michaillat and Mayer; Peters et al.; Zieger 
and Mayer; Schulze et al.). This dynamic nature allows for the redistribution of substrates 




Cell-type Specific Secretory Lysosomes 
Secretory lysosomes are a subset of organelles that are indistinguishable from 
lysosomes, or they can be a distinct subset of organelles that are present in cells that also 
contain “traditional” lysosomes. The function of these LROs varies depending upon the 
cell type. Most cell types contain secretory lysosomes involved in plasma membrane 
repair (Jaiswal, Andrews and Simon; Bansal et al.; Keefe et al.; Zhang et al.; Laulagnier 
et al.; Xu et al.; McNeil; McNeil and Kirchhausen). Plasma membrane injury can occur 
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due to mechanical stress (e.g., muscle, skin, endothelial cells and adipocytes) or by 
pathogens trying to gain access to host cells (e.g., pore-forming toxins generated by 
bacteria). Scientists have taken advantage of plasma membrane repair mechanisms to 
introduce reagents (DNA, immunoglobulins, drugs) into cells by electroporation, glass-
bead disruption or scrape-loading methods. The repair of the plasma membrane occurs 
within seconds/minutes and is essential for survival. This process involves the influx of 
calcium, which binds to the phospholipid-binding protein synaptotagmin VII (Andrews, 
Almeida and Corrotte), triggering interaction with soluble N-ethylmaleimide-Sensitive 
Factor (NSF) Attachment protein Receptors (SNAREs) such as SNAP-23, which are 
necessary for membrane fusion and cytoskeletal rearrangement. The fusion of lysosomes 
at the wound site results in lysosomal hydrolases being released extracellularly and the 
presence of lysosomal membrane proteins including LAMPs, LIMPs and the vacuolar 
H+-ATPase localized at the cell surface. A lysosomal enzyme, acid sphingomyelinase, 
has been shown to be important for the restoration of plasma membrane integrity (Tam et 
al.). Data suggest that the transient plasma membrane localization of the vacuolar H+-
ATPase may provide the necessary pH conditions for acid sphingomyelinase to function 
at the outer leaflet of the plasma membrane generating ceramide (Xu et al.), which 
produces an inward bulging of the plasma membrane and the dynamin-independent 
internalization of the wound repair site (Idone et al.; Lariccia et al.; Sinha et al.; Jiang and 
Chen). The endocytosis of the wound patch allows for the recovery of the lysosomal 
membrane proteins. Defects in plasma membrane repair are associated with a broad range 
of human diseases including neurodegeneration, muscular dystrophy, lysosomal storage 
diseases, heart disease, skin disorders and obesity. 
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Hematopoietic-lineage Secretory Lysosomes 
Distinct subsets of secretory lysosomes are found in the cells that belong to 
hematopoietic lineages such as lymphocytes, granulocytes (eosinophils, neutrophils, 
basophils, mast cells), platelets and macrophages. These vesicles contain cell type-
specific molecules that are involved in disease-related processes including pathogen 
killing, lysing virally or bacterially infected cells and lysing tumourigenic cells. The 
secretory lysosomes are also involved in homeostatic processes including promoting 
coagulation and antigen presentation in innate and adaptive immune responses. 
In Cytotoxic T Lymphocytes (CTLs), the LROs or lytic granules are the only 
lysosomes present in the cells. They store acid hydrolases to degrade endocytosed 
material but also contain secretory molecules such as perforin and granzymes. They 
function at neutral pH to insert into target cell membranes at the immunologic synapse 
forming a pore that can result in target cell killing (Holt, Gallo and Griffiths; Luzio, Pryor 
and Bright; Pattu, Halimani, et al.; Figure A.1). Another important molecule contained in 
small vesicles within these secretory lysosomes is Fas Ligand (FasL), a transmembrane 
protein that is released in small vesicles when the lysosomes fuse with the plasma 
membrane at the immunologic synapse (Zuccato et al.). The small vesicles then fuse with 
the target antigen-presenting cell that contains Fas and this recognition triggers apoptosis. 
Loss of FasL gives rise to Autoimmune Lymphoproliferative Syndrome, or ALPS1B (Wu 
et al.). The release of the lytic granule contents at the immunologic synapse provides a 
restricted “barrier” to protect against unwanted killing of neighboring cells. 
Some of the mechanisms for lytic granule release have been elucidated through 
the use of inhibitory molecules (e.g., microtubule depolymerizing agents such as 
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nocodozole or nonhydrolyzable nucleotides (GTPgS or ATPgS) and through the 
identification of human mutations in genes encoding required components. Two such 
components are the ras related small GTPase (Rab) Rab27a, which is required for 
docking of the lytic granule at the plasma membrane, and Munc13-4, which is an effector 
molecule of Rab27a that regulates fusion with the plasma membrane. Mutations in the 
genes that encode Rab27a (Menasche, Pastural, et al.; Desnos et al.; Menasche, 
Feldmann, et al.) or Munc13-4 (Feldmann et al.; Yamamoto et al.; Garrett et al.) result in 
defective cytotoxic T cell killing and human diseases (Griscelli syndrome and 
hemophagocytic lymphohistiocytosis, respectively). Several SNARE molecules (proteins 
on cognate donor and acceptor membranes that act as addressing molecules) required for 
lytic granule exocytosis in CTLs include Vamp8 (Loo et al.), Vti1b (Dressel et al.), 
Syntaxin7 (Pattu, Qu, et al.), Syntaxin11 (Bryceson et al.; Halimani et al.), Munc18-2 and 
Synaptobrevin2 (Matti et al.). Mutations in many of these genes in humans give rise to 
type 3-5 familial hemophagocytic lymphohistiocytosis, a life-threatening disease where 
the immune system produces too many activated immune cells that can damage major 
organs of the body (Faitelson and Grunebaum; Sieni et al.). Similar regulatory 
mechanisms for LRO secretion appears to exist in Natural Killer (NK) cells, although NK 
cells also have non secretory lysosomes that function to degrade endocytosed material 
(van der Sluijs, Zibouche and van Kerkhof). 
Neutrophils contain primary and secondary granules (LROs) that assist in the 
uptake and killing of bacteria. During phagosome formation the cell undergoes a change 
in the localization of the Microtubule-Organizing Center (MTOC) toward the forming 
phagosome (Tapper, Furuya and Grinstein). The primary granules can fuse with the 
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phagosomal membrane and release of granule content assists in bacterial killing. The 
contents of the granules are very specific. Primary or azurophilic granules contain 
proteases such as elastase, Cathepsin G, antimicrobial peptides and myeloperoxidase. 
Secondary granules contain lactoferrin and lysozyme, which are directed, respectively, at 
limiting bacterial iron acquisition and lysis of pathogen cell walls. 
Basophils and mast cells have secretory lysosomes that act in inflammation often 
associated with allergic reactions. They contain acid hydrolases along with various 
inflammatory mediators such as histamine, heparin, serotonin and neutral proteases 
(Marone et al.). Eosinophilic secretory lysosomes are associated with host defense 
against parasitic helminthes, allergic reactions and immunoregulation. The granules 
contain a variety of molecules including cationic proteins, growth factors, cytokines, 
receptors, and lytic molecules. The selective sorting of these molecules into eosinophil 
granules as well as their regulated release has identified different mechanisms that 
mediate release of granule contents (Muniz, Weller and Neves). These mechanisms 
include: 1) compound exocytosis where the entire granule fuses with the plasma releasing 
its contents to kill target cells or parasites; 2) selective secretion of specific contents 
through tubular/vesicular structures that are released from the secretory lysosomes and 
fuse with the plasma membrane to release their contents; and 3) whole cell eosinophil 
lysis, which releases intact granules that may be directed to target cells or pathogens via 
membrane recognition molecules. 
Macrophages contain conventional lysosomes, as well as secretory lysosomes that 
are involved in membrane repair, pathogen killing and immunomodulation. Specialized 
macrophages such as osteoclasts utilize these secretory lysosomes to deliver acid 
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hydrolases to sites of bone resorption (Teitelbaum). These secretory lysosomes contain a 
subset of acid hydrolases, including cathepsin K and tartrate-resistant acid phosphatase or 
TRAP, two enzymes that play a role in bone resorption, which is critical for skeletal 
formation and remodeling (van Meel et al.). Some of the molecules that have been 
implicated in the release of secretory lysosomes in osteoclasts include Synaptotagmin VII 
(Zhao et al.), Syntaxin4, and Rab7. 
The megakaryocyte, the platelet-forming cell, contains secretory and conventional 
lysosomes. Platelets, which are only found in mammals, are formed by the shedding or 
breaking off of fragments of the megakaryocyte into the bloodstream. Platelets contain 
three kinds of secretory lysosomes: dense core granules containing clotting factors 
(fibrinogen, Von Wiebrand Factor, nucleotides), alpha granules containing 
vasoconstricting factors (serotonin, calcium), and lysosomes containing acid hydrolases 
and clot remodeling factors (Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin 
Activatable Fibrinolysis Inhibitor (TAFI)) (Flaumenhaft et al, 2009, Italiano et al, 2008). 
These secretory lysosomes can also release a number of chemokines and cytokines, 
which promote activation of leukocytes for immune response (Ren, Ye and Whiteheart). 
Secretory lysosomes must be moved to the periphery of the megakaryocyte prior to 
shedding of platelets. A failure to appropriately move vesicles will result in coagulation 
defects, which is a common phenotype associated with human diseases such as Chediak-
Higashi Syndrome, Hermansky-Pudlak Syndrome, Gray Platelet Syndrome and 
Griscelli’s Syndrome. Some details of these human diseases associated with secretory 
lysosome defects will be described later in this chapter. The basic machinery that moves 
and fuses vesicles with the plasma membrane is conserved for all secretory lysosome 
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release, however, there are cell type specific molecules that mediate this process. 
Molecules required for platelet dense granule release have been characterized through 
human disease gene identification, mouse knockouts and platelet dense granule 
proteomics (Lemons et al.; Flaumenhaft et al.; Chen et al.; Lemons, Chen and 
Whiteheart; Reed). More recently syntaxin-binding protein 5 was shown to bind to core 
secretion machinery regulating when and where SNARE interactions occur, and the 
knockout mouse showed defective hemostasis and bleeding tendencies (Ye et al.). The 




Nonhematologic Cell Secretory Lysosomes 
While the specialization of secretory lysosomes is most pronounced in 
hematopoietic cell lineages, all cells have secretory lysosomes. The endothelial cell 
contains a specialized secretory lysosomes termed Weibel-Palade bodies (Weibel and 
Palade), which play a key role in wound repair and coagulation (Hannah et al.). These 
secretory vesicles contain the von Willebrand factor, which is important in blood clotting 
(Sakariassen, Bolhuis and Sixma; Ewenstein et al.; Ruggeri), as well as the membrane 
protein P-selectin (Bonfanti et al.; McEver et al.), which recruits leukocytes that play a 
role in initiating inflammation (Dore et al.; Mayadas et al.; Nolte et al.).   
Astrocytes, neurons and pulmonary type II cells have also been shown to contain 
specialized secretory lysosomes (Zhang et al.; Tribl et al.; Weaver, Na and Stahlman) that 
function in ATP, pigment and surfactant storage and regulated release.   
The discovery that melanosomes are secretory lysosomes in pigment cells has 
provided much of the basis for understanding basic LRO biogenesis and plasma 
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membrane release. This work was initiated by the observation that there were human 
diseases associated with pigmentation defects and that affected individuals often showed 
defects in hemostasis and immune function. Along with the more detailed 
characterization of these human diseases, mouse geneticists noticed that several 
spontaneously occurring mouse strains possessed varying levels of coat color defects and 
those mice often showed defects in other secretory lysosome functions (Jackson). The 
combination of these two observations provided the tools to identify those genes 
responsible for pigmentation and the biochemical pathways regulating LRO formation, 
movement and function. During their development, melanosomes contain enzymes and 
scaffolding proteins along with several ion channels necessary for the synthesis of 
complex pigments. These pigments provide photoprotection from ionizing radiation and 
regulate retinal function in the eye (Raposo and Marks). The biogenesis of these 
organelles follows a highly specialized endocytic trafficking pathway (Wu and Hammer), 




Biogenesis of Lysosomes and Secretory Lysosomes 
The generation of secretory lysosomes follows the same pathway as lysosome 
biogenesis. The delivery of internalized membrane through endocytosis provides a 
pathway for selective sorting. Endosomes proceed through a series of sorting events 
where receptors and other plasma membrane components are recycled (e.g., transferrin 
receptor) as the endosome is “matured.” Cargo destined for degradation remains in the 
endosome. The maturing endosome invaginates to form the Multivesicular Body (MVB) 
through a series of specific protein recruitment events that are regulated by the 
 	  
67 
Endosomal Sorting Complexes Required for Transport (ESCRT)-dependent machinery. 
Ubiquitin “marked” membrane proteins are sorted into intraluminal vesicles that will be 
delivered to the lysosome for degradation. Again, much of this work was initially done in 
S. cerevisiae (Babst, Katzmann, Estepa-Sabal, et al.; Babst, Katzmann, Snyder, et al.; 
Katzmann, Babst and Emr; Babst and Odorizzi; Henne, Stenmark and Emr), but a great 
deal of the knowledge on the mechanisms involved in MVB formation has come about 
through the study of virus release, specifically Human Immunodeficiency Virus (HIV) 
(Votteler and Sundquist) and cell abscission (Carlton and Martin-Serrano; Morita et al.). 
There are currently over 20 ESCRT proteins in mammals and their roles in MVB 
formation, sorting and trafficking and other cellular process such as abscission and 
exosome release are still being defined (McCullough, Colf and Sundquist; Schuh and 
Audhya). 
Hydrolases and other soluble lysosomal components, synthesized in the ER and 
trafficked through the Golgi for additional glycosylation, can be delivered to the now late 
endosome through Mannose 6-Phosphate Receptors (M6PR), which release their cargo 
upon exposure to the acidic environment of the forming lysosome (Fischer et al.; 
Kornfeld and Mellman; Braulke and Bonifacino; Saftig and Klumperman). Other 
delivery mechanisms independent of M6PR are known to exist, as hydrolases can be 
delivered to lysosomes in the absence of M6P glycosylation, as in the human disorder I-
cell disease due to a deficiency in N-acetylglucosamine-phosphotransferase (Coutinho, 
Prata and Alves). Membrane proteins destined for residence in lysosomes contain 
targeting motifs, YXXf or [DE]XXXL[LI], which are recognized by Adaptor Proteins 
(AP) that sort them into coated cargo vesicles for delivery with the late endocytic 
 	  
68 
machinery (Park and Guo). This can occur in the biosynthetic pathway via AP1 or AP3 or 
via an indirect route to the plasma membrane where the adaptor protein AP2 assists in the 
recognition and endocytosis of lysosomal proteins. There is also evidence that lysosomal 
membrane proteins such as LAMP1 and LAMP2 can be delivered to the forming 
lysosome in an AP-independent M6PR-independent manner (Pols et al.). 
The mechanisms for sorting to conventional lysosomes also provide for the 
sorting of molecules to secretory lysosomes. There are some specialized sorting 
mechanisms in CTL secretory lysosome biogenesis that involve ubiquitination and 
phosphorylation of FasL and trafficking through the MVB for delivery to LROs (Park 
and Guo ). Consistent with cell type-specific secretory lysosome sorting is the trafficking 
of elastase into neutrophils through the tetraspanin molecule CD63 (Harrison-Lavoie et 
al.). The sorting of molecules into the forming melanosomes is highly specific for 
melanocytes and deviates from typical secretory lysosome formation by sorting from the 
early rather than late endosomal compartment; in addition, there are no internal vesicles 




Exocytosis of Secretory Lysosomes 
The regulated secretion of LROs has some general principles that apply to all cell 
types (Figure A.2). The first step in secretion is signaling to the cell to release secretory 
lysosomes. This signal can be the influx of calcium, as in wound repair or it may be a 
receptor ligand signal, as in CTLs or NK cells where the formation of the immunologic 
synapse (TCR-antigen-MHC) signals the polarization of the cell and the movement or 
localization of “mature” secretory lysosomes near the plasma membrane. However, not 
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all cells polarize to release secretory lysosome contents. Secretion requires binding of the 
secretory lysosome to microtubules through the kinesin family of motor proteins 
providing long distance movements toward the cell periphery. The secretory lysosome is 
then released and may bind to actin through myosin motors for more subtle movements 
close to the plasma membrane. Once the secretory lysosome is near the plasma 
membrane, docking molecules on the secretory lysosome and plasma membrane tether 
the vesicle to the plasma membrane. Finally, SNARE pairing brings the secretory 
lysosome membrane in close proximity with the plasma membrane, where the SNARE 
pairing and Rab molecules can affect a fusion event. Thus releasing soluble secretory 
lysosome content, as well as delivering membrane content to the plasma membrane. The 
mechanisms that regulate granule release have not been fully elucidated for each cell 
type, however, some calcium sensing molecules such as synaptotagmin VII and tethering 
molecules including synaptobrevin2, Munc13-4 and Munc18-2 along with SNARE 
molecules Vamp7, Vamp8, Vamp2, Syntaxin4, Syntaxin7, SNAP-23, have been 
suggested to have a role in cell-specific secretory lysosome release (Logan et al.; Tiwari 
et al.; Lacy et al.; Suzuki and Verma). Further, novel SNARE regulatory molecules have 




Genetic Diseases Associate with Defects in Conventional or 
Secretory Lysosomes 
There are many human diseases associated with defects in conventional lysosome 
or LRO function or biogenesis and patients have been identified and described for many 
decades. Some of the diseases associated with conventional lysosome defects include 
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Lysosomal Storage Diseases (LSDs), which are classified according to the substrates they 
accumulate. These include mucolipidosis, sphingolipidoses, oligosaccharidoses, 
lipoprotein storage disorders, mucopolysaccharidosis and neuronal ceroid lipofuscinoses 
along with others; up to 50 have been described (Coutinho, Matos and Alves; Samie and 
Xu). These disorders are most often due to mutations in lysosomally targeted enzymes 
that degrade their specific substrates or mutations in the proteins that regulate the 
delivery of these enzymes to the lysosome. The resulting phenotype commonly 
associated with LSDs is the abnormal accumulation of undegraded substrates. Examples 
of LSDs that are not due to mutations in the enzymes include mucolipidosis type 4, where 
there is a defect in the cation channel mucolipin-1 and Niemann-Pick type C disease, 
which is due to mutation in either NPC1 or NPC2 (Ikonen and Holtta-Vuori; Vanier). It is 
unclear what ion is important in mucolipid degradation or what ion(s) mucolipin-1 
transports (Dong, Cheng, et al.; Dong, Shen, et al.; Eichelsdoerfer et al.). The exact roles 
of NPC1 and NPC2 in cholesterol metabolism have not been fully elucidated, but they 
may play a role in sterol transport. Treatment for many of these LSDs is enzyme 
replacement therapy. 
Other genetic diseases associated with the biogenesis, trafficking or homeostasis 
of lysosomes and secretory lysosomes that are not due to substrate accumulation include: 
Hermansky-Pudlak Syndrome (HPS), Griscelli’s Syndrome (GS), Chediak-Higashi 
Syndrome (CHS), Gray Platelet Syndrome (GPS), and Familial Hemophagocytic 
Lymphochistiocytosis (FHL). There are nine subtypes of HPS. Phenotypes associated 
with HPS include pigmentation defects of the hair, skin and eyes, bleeding tendencies, 
neurologic disorders and in some HPS cases pulmonary fibrosis. Mutations in HPS-
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associated genes encode for proteins that are involved in the biogenesis of secretory 
lysosomes (e.g., AP3, BLOCs, geranylgeranyl transferases). As of yet there is no cure for 
HPS and there is a great deal of heterogeneity of HPS-associated defects (Seward and 
Gahl).  
There are three types of GS, which can vary in phenotype with partial albinism 
being the common phenotype, but can include immunodeficiency or neurologic deficits. 
The genes associated with GS encode for proteins involved in the movement of LROs 
(e.g., Myosin-Va, Rab27a and melanophilin). There is no cure for GS but the 
hematologic problems can be treated with bone marrow transplantion (Arico et al.; 
Cesaro et al.; Trottestam et al.). 
CHS phenotypes include severe immune deficiency, hypopigmentation, bleeding 
tendency, frequent bacterial infection, oculocutaneous albinism, and progressive 
neurological dysfunction (Spritz). The hallmark characteristic of CHS is the presence of 
giant conventional and secretory lysosomes in all cells of the body (Introne, Boissy and 
Gahl; Shiflett, Kaplan and Ward; Stinchcombe, Bossi and Griffiths). The identification of 
the gene responsible for CHS was done through classic positional cloning of CHS 
patients and yeast artificial chromosome complementation using the beige mouse model 
(Perou, Justice, et al.; Perou, Moore, et al.; Barbosa et al.; Nagle et al.). The CHS/LYST 
gene encodes a protein of 3800 amino acids containing three to four defined domains or 
motif that have not informed on function (Kaplan, Domenico and Ward); although, the 
WIDL and WD-40 repeat domains defined a family of protein called Beige And Chediak 
(BEACH) and all family members that have been characterized appear to be involved in 
membrane trafficking (Cullinane, Schaffer and Huizing). There are two competing 
 	  
72 
hypotheses for the function of Lyst, one suggesting that Lyst functions as a negative 
regulator of fusion (Barrat et al.; Kypri et al.; Charette and Cosson; Rahman et al.; Kypri, 
Falkenstein and De Lozanne) and the other suggesting that Lyst regulates lysosome 
fission (Perou, Leslie, et al.; Durchfort et al.). It is of interest to note that only CHS, as 
opposed to HPS, GS or GPS, is associated with defects in conventional lysosomes, as 
well as LROs suggesting that the Lyst protein regulates the maintenance or biogenesis of 
both types of lysosomes. Treatment for CHS is prophylactic antibiotics early in life and 
bone marrow transplant, which treats the life-threatening immunologic deficits but does 
not treat the neurologic defects.  
GPS is a rare autosomal recessive bleeding disorder that is due to a reduction or 
the absence of alpha granules in platelets. The gene identified to be mutated in GPS is 
NBEAL2, which is a member of the BEACH family of proteins involved in vesicular 
trafficking (Kahr et al.). A mouse model of the disease demonstrated the importance of 
Nbeal2 in hemostasis and thrombosis and tissue repair (Deppermann et al.). 
Familial Hemophagocytic Lymphochistiocytosis (FHL) patients are 
immunodeficient but do not exhibit pigmentation defects. FHL is manifested in the first 
six months of life and is historically treated with bone marrow transplantation (Jabado et 
al.), or more recently with stem cell transplantation (Ohga et al.). It can be caused by 
mutations in the PRF1 gene, which encodes for perforin, the protein that plays an 
important role in CTL-mediated killing or in the gene encoding Munc13-4 (Feldmann et 
al.). Munc13-4 protein is essential for the secretion of secretory vesicles from CTL but 
not from melanocytes or neuronal cells. FHL patients’ secretory lysosomes are able to 
transport and dock to the plasma membrane, but are not able to release their content in 
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immunological synapse due to the mutation of Munc13-4. The loss of perforin mediated 
cytotoxicity results in imbalanced immune homeostasis and deregulated activation and 





The biosynthesis of lysosomes and secretory lysosomes involves multiple 
trafficking pathways including delivery of cargo to the forming lysosome from the 
endocytic and biosynthetic pathways, along with recycling of membrane constituents 
needed for further rounds of targeting to the lysosome. There is clear evidence that these 
organelles are capable of fusion and fission events and the machinery that regulates this 
process is being elucidated. One of the major limitations in understanding the biogenesis 
of lysosomes and secretory lysosomes is the ability to distinguish between late 
endosomes and lysosomes. Currently there are no clear markers of lysosomes, as late 
endosomes receive “lysosomal” cargo to be delivered to the forming lysosome. Further, 
we do not understand many of the molecules that are involved in lysosome or secretory 
lysosome fission. 
Many of the molecular components required for secretory lysosome biogenesis 
and secretion have been determined, however, it is clear that the detailed biochemical 
requirements for this process need to be better understood. That particular cell types have 
evolved mechanisms to generate and release secretory lysosomes further demonstrates 
the complexity of this process. The recent advances in live cell microscopy, protein 
tagging and proteomics should provide some of the tools necessary to identify the roles of 
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Figure A.1: A model of the immunologic synapse in Cytotoxic T Lymphocytes 
(CTLs) secretory lysosome release  
T-cell receptors on CTL recognizes antigen on antigen presenting cell in the context of 
MHC forming the immunologic synapse. This recognition sends a signal that causes the 
CTL centromere to polarize toward the immunologic synapse. Secretory lysosomes 
engage the microtubule machinery to move them toward the plasma membrane at the 
immunologic synapse. These lytic granules contain Fas Ligand (FasL) that recognizes 
Fas being expressed on the antigen presenting cell. They also contain the pore forming 
protein perforin and granzymes, which upon release at the synapse form a pore in the 
plasma membrane that induces apoptosis of the antigen presenting cell. Included is a list 






Figure A.2: A model of secretory lysosome release  
1) A signal is transduced by receptor-ligand interaction, an intracellular signal or by 
wound formation at the plasma membrane triggering a calcium release from intracellular 
stores. 2) SynaptotagminVII (Syn) binds to the secretory lysosome in response to calcium 
and 3) the vesicle moves toward the MTOC. 4) The secretory lysosome then engages the 
MT through the motor protein kinesin to move to the periphery of the cell where it is 
released. 5) For the short movement to the plasma membrane the secretory lysosome 
engages actin cytoskeletal elements through myosin motors. 6) When the vesicle is in 
close proximity to the plasma membrane, recognition membrane docking elements (stars) 
bind the docking elements on the vesicle. 7) The specific vesicular and plasma membrane 
v and t-SNAREs bind and bring the vesicle near the plasma membrane and fusion occurs 
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